Effect of Thiazolidinedione Treatment Vascular Risk Markers
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the effects of two diabetes medications,
rosiglitazone and pioglitazone, on markers of vascular disease in subjects with type 2
diabetes.